4
Changes in Ownership
Veradermics, Inc Filed Acc 0001628280-26-005897
Chief Executive Officer acquired 1,437 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waldman Reid Alexander Chief Executive Officer | 2026-02-05 | Conversion | +1,437 | 234,872 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Waldman Reid Alexander Chief Executive Officer | 2026-02-05 | Conversion · Series A Convertible Preferred Stock | −1,437 | 0 | D: show line 2 in the form | |||||
| Waldman Reid Alexander Chief Executive Officer | 2026-02-03 | Grant or award · Stock Option (Right to Buy) | +556,399 | 556,399 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1770336007.xml…